Peer Review History
| Original SubmissionMay 29, 2021 |
|---|
|
PONE-D-21-17814Guideline adherence in speech and language therapy in stroke aftercare. A health insurances claims data analysisPLOS ONE Dear Dr. Schindel, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please respond to reviewers and resubmit for reconsideration. Please submit your revised manuscript by Nov 05 2021 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols. We look forward to receiving your revised manuscript. Kind regards, Marie Jetté Academic Editor PLOS ONE Journal requirements: When submitting your revision, we need you to address these additional requirements. 1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 2. Please include your tables as part of your main manuscript and remove the individual files. Please note that supplementary tables (should remain/ be uploaded) as separate ""supporting information"" files 3. We note that the grant information you provided in the ‘Funding Information’ and ‘Financial Disclosure’ sections do not match. When you resubmit, please ensure that you provide the correct grant numbers for the awards you received for your study in the ‘Funding Information’ section. 4. In your Data Availability statement, you have not specified where the minimal data set underlying the results described in your manuscript can be found. PLOS defines a study's minimal data set as the underlying data used to reach the conclusions drawn in the manuscript and any additional data required to replicate the reported study findings in their entirety. All PLOS journals require that the minimal data set be made fully available. For more information about our data policy, please see http://journals.plos.org/plosone/s/data-availability. Upon re-submitting your revised manuscript, please upload your study’s minimal underlying data set as either Supporting Information files or to a stable, public repository and include the relevant URLs, DOIs, or accession numbers within your revised cover letter. For a list of acceptable repositories, please see http://journals.plos.org/plosone/s/data-availability#loc-recommended-repositories. Any potentially identifying patient information must be fully anonymized. Important: If there are ethical or legal restrictions to sharing your data publicly, please explain these restrictions in detail. Please see our guidelines for more information on what we consider unacceptable restrictions to publicly sharing data: http://journals.plos.org/plosone/s/data-availability#loc-unacceptable-data-access-restrictions. Note that it is not acceptable for the authors to be the sole named individuals responsible for ensuring data access. We will update your Data Availability statement to reflect the information you provide in your cover letter. Additional Editor Comments (if provided): [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Yes Reviewer #2: Partly ********** 2. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: Yes Reviewer #2: Yes ********** 3. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes Reviewer #2: Yes ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: No Reviewer #2: No ********** 5. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: Manuscript #: PONE-D-21-17814 Title: Guideline adherence in speech and language therapy in stroke aftercare. A health insurances claims data analysis Article type: Research Article Summary In this manuscript, the authors defined six test parameters to measure how well speech-language therapy (SLT) aftercare aligned with clinical practice guidelines. The authors used claims data from four health insurance companies in Germany for their dataset. The findings of this manuscript are important because they shed light on reasons that individuals following stroke do not receive SLT aftercare. The overall concept and methods of this manuscript are strong, but revisions are needed prior to publication. Overall, the manuscript is difficult to read because of awkward phrasing, grammatic errors, and missing punctuation. The authors should edit the entire manuscript to improve grammar, capitalization, punctuation, phrasing, and clarity. Appropriate capitalization is particularly lacking in the tables. In addition, the following should be addressed: Abstract The authors mention that six test parameters were defined. Please provide one or two examples of the test parameters so that readers get a better idea of the content (Line 30). Introduction 1. On line 59, the authors state that there are clinical practice guidelines for the treatment of aphasia, dysarthria, and dysphagia, but no references are provided. Please provide citations for established or recommended clinical practice guidelines. Methods 1. Is there a name of the “local stroke registry” that can be provided (Line 96)? 2. Data extraction was conducted by “three scientific researchers”, but only two are described (Line 113). 3. Unless validity was tested, please remove “valid” from this sentence: “In total, five valid and specific testable parameters for SLT provision were extracted from the guidelines.” If validity was established, please indicate the type. (Line 117) 4. In describing parameter 1, the authors state that “…we defined having at least two specific diagnoses as mandatory to determine a need of ambulatory SLT” (Line 120). This appears to contradict the fourth column in Table 1 which states that the parameter was measured by “invoice of services for patients with at least one specific speech disorder diagnosis.” Please reconcile the wording of these two descriptions of parameter 1. Also, please include which specific diagnoses were included for parameter 1 in the Methods section. 5. Please provide a citation to support this sentence, if able: “Due to spontaneous remission and early inpatient therapy of disorders, we defined having at least two specific diagnoses as mandatory to determine a need of ambulatory SLT.” (Line 120) 6. The sentence that begins with “Third, guidelines recommend…” suggests that there were two sentences earlier that began “First,…” and “Second,…”. Please revise accordingly (Line 126). 7. Table 1 states that therapy duration of 60 minutes is recommended. Please add this criterion to the Methods section (around Line 130). Also, for clarity, the therapy durations for parameter 4 should be described in the same way in the Methods section and Table 1 (e.g., group 1: > 60 minutes; group 2: <60 minutes) (Line 133). 8. Table 1 states that parameter 5 is that a high frequency of therapy is recommended, with at least two sessions per week. Please add this specification to the relevant part of the Methods section (around Line 135). 9. Did the authors create the GAS, or has it been published previously? If it is based on a published method, please provide a citation. Results: 1. Within the Results section, please specific the number and percentage of the sample that were diagnosed with dysarthria, aphasia, and dysphagia, and reference Table 2 (Lines 173-174). 2. In accordance with person-first language, consider changing “TIA patients” to “Patients following TIA…” (Line 180). Please use person-first language throughout the manuscript. Also, please define “TIA” the first time you use the abbreviation (i.e., transient ischemic attack (TIA)). 3. Please ensure that the tense of the Results section is consistent within paragraphs (e.g., past tense). 4. Please specify when treatment is “SLT” treatment throughout the article, because individuals following stroke are often seen by multiple services (e.g., “… increase the likelihood of receiving earlier and continuous care after discharge…”) (Line 207). 5. Please reference a table for the description of findings of parameter 5 and GAS (Lines 214-220). Also, please make it clearer if the description of parameter 5 findings are hypotheses or results (Lines 214 – 216). Discussion: 1. Please revise the sentence that starts (“A final evaluation requires…”) (Line 228) which is difficult to understand. 2. The discussion section titled “Speech therapists” needs to be revised to improve flow and coherence. Presently, it is difficult to understand the main points that the authors are communicating. 3. The sentence at the beginning of the “Specific diagnostics” discussion section is unclear: “The prerequisite for appropriate treatment is correct diagnosis, which seems to have occurred in a large majority of cases.” (Line 259). As this is a retrospective analysis of claims data, it is impossible to know if correct diagnoses were made. Please revise. 4. In the “Early onset and continuity” discussion, the authors report that half of their patients started SLT aftercare within two weeks after discharge, and mention reports from other parts of the world that have slower initiation of treatment. It might be helpful for the authors to suggest possible reasons that the German healthcare system may be able to initiate earlier services. (Line 275) 5. An article that might help support the concern described in the third sentence of the Limitations section, is: González-Fernández, M., Gardyn, M., Wyckoff, S., Ky, P. K. S., & Palmer, J. B. (2009). Validation of ICD-9 code 787.2 for identification of individuals with dysphagia from administrative databases. Dysphagia, 24(4), 398–402. 6. In the US, we have the same problem with SLT diagnoses not being represented well in claims data as you describe in Lines 344-345. I have no revision request for this point. Table 1. 1. This is a very useful table that makes it clear how the test parameters were generated and quantified. Please add appropriate capitalization throughout the table. 2. The third recommendation “early onset and continuity” should be described more clearly (e.g., “early initiation of therapy and continuity”). It is described clearly in the text of the article, but it is not described as well in the table. Table 2. 1. In the first column under “age (median, IQR)”, “25” and “75” should have percent signs following the numbers if these are quartiles of the IQR. 2. Please change the title to something clearer, such as “Sample Characteristics: SLT vs. No-SLT Reviewer #2: This manuscript describes efforts to define and test the typical clinical implementation of guidelines for SLT driven care for patients who are post-stroke with diagnosed aphasia, dysarthria, and/or dysphagia. The authors reviewed international and national (German) guidelines. Six applicable guidelines were identified. Using claims data from 4,486 stroke patients, the investigators determined the degree to which care complied with guidelines and explored factors that might be associated with guideline non-compliance. Overall, the article provides important information that contributes to the emerging literature base that demonstrates that SLT care often does not adhere to guidelines, especially have patients are discharged from the acute stroke hospitalization. While many factors are adequately accounted for, stroke severity is not. Stroke severity likely plays a major role in patients receiving SLT. In this study, length of initial acute hospitalization was used as a proxy for stroke severity. There are other published markers of stroke severity which should be incorporated to allow for better interpretation and application of the results. However, even without strong stroke severity data, this manuscript calls attention to a very large issue in the field – guidelines for SLT care for the post-stroke population are generally not adhered to. Given the magnitude of the issue, a paragraph about Clinical Relevance at the end of the discussion section detailing the guidelines that are not uniformly adhered to would be helpful to calling clinician and healthcare management attention to the results. Specific Questions/Issues: 1. Lines 120-121: It is unclear what is meant by at least 2 diagnoses. Please specify. If what is meant is stroke + aphasia, dysarthria, or dysphagia, then this makes sense. If it refers to something else, please provide further justification. 2. Lines 181-182: This sentence seems to refer to patients already or previously being treated by an SLT prior to the incident stroke (stroke that got them enrolled in the current retrospective study). If so, please provide more information. 3. Lines 184-187: It is unclear what is meant by the results in these 3 sentences. Please rephrase. 4. The discussion seems to under interpret the seriousness of the issue. Of 83% of post-stroke patients with an SLT diagnosis, only 38% of those received SLP services. Please strengthen the discussion related to this. 5. In Table 2, why are so few instances of SLT, incontinence, gait, or paralysis coded for the first stay utilization. 6. Please add a Clinical Relevance section at the end of the discussion section detailing the guidelines that are not uniformly adhered to would be helpful to calling clinician and healthcare management attention to the results. 7. Please add as a limitation the lack of direct measure of stroke severity and the issues with using LOS of first hospitalization as a proxy. ********** 6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No Reviewer #2: No [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step. |
| Revision 1 |
|
PONE-D-21-17814R1Guideline adherence in speech and language therapy in stroke aftercare. A health insurance claims data analysis.PLOS ONE Dear Dr. Schindel, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Specifically, please respond to Reviewer 1's revision requests. Please submit your revised manuscript by Jan 28 2022 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols. We look forward to receiving your revised manuscript. Kind regards, Marie Jetté Academic Editor PLOS ONE [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation. Reviewer #1: All comments have been addressed Reviewer #2: All comments have been addressed ********** 2. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Yes Reviewer #2: (No Response) ********** 3. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: Yes Reviewer #2: (No Response) ********** 4. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes Reviewer #2: (No Response) ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: No Reviewer #2: (No Response) ********** 6. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: Manuscript #: PONE-D-21-17814R1 Title: Guideline adherence in speech and language therapy in stroke aftercare. A health insurances claims data analysis Article type: Research Article Summary The authors have carefully responded to the reviewer comments and revised their manuscript accordingly. There are some additional minor concerns that have been identified (below) that could be addressed. Additionally, there are several remaining grammatical issues. It would likely improve the readability of the manuscript if it was proofread/revised in its entirety for English grammar again. If these minor issues are addressed satisfactorily, it is likely that this manuscript could be accepted. Abstract In the sentence that starts “Treatment oriented on medical guidelines…”, the word “medical” could be misleading, as it often refers to medication. Perhaps this could be changed to “evidence-based guidelines” or something similar. As Reviewer 2 points out, using hospitalization duration as a proxy for stroke severity is not ideal. To make the abstract more clearly represent the data, please revise the sentence that starts “Older age and increasing severity of stroke…” by replacing “severity of stroke” with “hospitalization duration”. The abstract seems to be missing some of the most salient findings of the paper. Please consider including in the Results section of the Abstract that of the 90.3% of post-stroke patients with an SLT diagnosis, only 44.1% received outpatient SLP services within the first year post-stroke. Methods In the Guideline parameters to test for adherence section: From the sentence that starts “Extraction of parameters”, please delete “were involved” from the end of the sentence (Lines 119-121). Also, please add a comma after “medical doctor”. In the Guideline parameters to test for adherence section: Please add a colon after the sentence that starts “In total, five specific testable…” Otherwise, the sentence that follows is hard to interpret. (Lines 125-126). In the Guideline parameters to test for adherence section: It is still difficult to interpret the sentence that includes, “we defined having at least two specific diagnoses of speech disturbance ...” (Lines 127 – 131). Perhaps you could add the specific ICD-10-GM codes for aphasia and dysarthria (R47.01?) and separate these two conditions in the sentence (e.g., “aphasia (ICD-10-GM code R47.X), dysarthria (ICD-10-GM code R47.X”)) so that the sentence is clearer. Presently, it looks like dysarthria and aphasia have the same ICD-10 code. Results The last sentence of the Patients with SLT subsection needs to be revised (“Patients receiving aftercare SLT were more frequently and for a longer period in rehabilitation measures after the initial stroke”). (Lines 204-205) Discussion In the second sentence of the first paragraph of the Discussion, it would be helpful to clarify that hospitalization duration was used as a proxy for stroke severity by putting this information in parentheses (i.e., “patients with severe stroke (as captured by hospitalization duration)”). (Lines 256 - 258). Please make the fourth sentence of the first paragraph of the Discussion section clearer (“Younger patients needed more time for the take-up of aftercare speech therapies.”) (Line 259-260) Please revise the last sentence of the first paragraph of the Discussion section that starts “A final evaluation…” (Lines 261-262). Perhaps you could start the sentence with, “A deeper look into the data shows that …”, or something similar that hints to the reader what will be discussed in the remainder of the Discussion. In the first sentence of the Speech therapists subsection of the Discussion, do you mean “multiple diagnoses” rather than “repeated diagnosis”? Could you add swallowing impairments to this sentence? In the first paragraph of the Speech therapists subsection of the Discussion, please revise “Patients with less severe stroke or first stroke” to “Patients with less severe stroke or following an initial stroke”. (Lines 285-286) In the first paragraph of the Early Initiation and continuity subsection of the Discussion, please change “therapy resumption” in the first sentence to “therapy initiation.” (Line 324) Tables On Table 2, it might be helpful to revise the 7th row description from “Speech, language disorders: R47, R13” to “Dysarthria, aphasia, or dysarthria” (and add the relevant ICD-10 codes). Please include the raw number and percentage of the population for each of the three codes in the table (e.g., How many individuals had dysphagia?). Reviewer #2: (No Response) ********** 7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No Reviewer #2: No [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step. |
| Revision 2 |
|
Guideline adherence in speech and language therapy in stroke aftercare. A health insurance claims data analysis. PONE-D-21-17814R2 Dear Dr. Schindel, We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org. If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, Marie Jetté Academic Editor PLOS ONE Additional Editor Comments (optional): Reviewers' comments: |
| Formally Accepted |
|
PONE-D-21-17814R2 Guideline adherence in speech and language therapy in stroke aftercare. A health insurance claims data analysis. Dear Dr. Schindel: I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department. If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org. If we can help with anything else, please email us at plosone@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Dr. Marie Jetté Academic Editor PLOS ONE |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .